The company has asked users to monitor patients frequently to ensure the appropriate infusion is being delivered.

The move comes after a recent investigation found Chinese government procurement practices discriminate against EU companies ...

The companies scrapped the merger because securing FTC clearance “proved unviable in terms of time, expense and opportunity.” ...

Gaeta’s last role was a brief stint at Shockwave, which named her CFO two months before accepting J&J’s $13.1 billion ...

The latest fundraise included investors ARK Invest, Founders Fund, G42, Lightspeed, Sequoia Capital and others. Neuralink ...

Freenome plans to complete all modules of its premarket approval submission in mid-2025.

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

The startup received de novo authorization for the AI tool, the first of its kind that analyzes mammogram images to predict ...

The Trump Administration has effectively ended the Biden Administration's attempt to regulate lab-developed tests,” TD Cowen ...

Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for ...

CEO Sean Saint and CFO Stephen Feider spoke about what’s different now that the company is public and the long journey of ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...